Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Heterotopic Fresh Ovarian Graft in Young Woman With Locally Advanced Cervical Cancer Eligible for Pelvic Radiotherapy Treatment

NCT05462379 is registered in ClinicalTrials.gov with MARILIA ALBANEZI BERTOLAZZI as lead sponsor.

NCT NCT05462379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Heterotopic Fresh Ovarian Graft in Young Woman With Locally Advanced Cervical Cancer Eligible for Pelvic Radiotherapy Treatment
Lead sponsor
MARILIA ALBANEZI BERTOLAZZI
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
June 8, 2022
Completion date
April 1, 2027
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced cervical carcinoma, premature ovarian failure